Skip to search formSkip to main contentSkip to account menu

NNC 0756

Known as: NNC 756, NNC-0756, NNC-756 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

odapipam

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Behavioural evidence for “D-1-like” dopamine receptor subtypes in rat brain using the new isochroman agonist A 68930 and isoquinoline antagonist BW 737C
The full efficacy, high potency isochroman D-1 agonist A 68930 demonstrated greater than 220-fold selectivity for D-1 over D-2… 
2005
2005
Persistent vacuous chewing in rats following neuroleptic treatment: relationship to dopaminergic and cholinergic function
In order to relate the effects of pharmacological intervention to neuroleptic induced increases in oral activity rats were… 
1993
1993
Effect of chronic treatment with NNC 756, a new D-1 receptor antagonist, or raclopride, a D-2 receptor antagonist, in drug-naive Cebus monkeys: dystonia, dyskinesia and D-1/D-2 supersensitivity
When given subcutaneously in gradually increasing doses, up to 1 mg/kg, NNC 756, a dopamine (DA) D-1 antagonist, failed to… 
Highly Cited
1992
Highly Cited
1992
NNC-112, NNC-687 and NNC-756, new selective and highly potent dopamine D1 receptor antagonists.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)